Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Specific transfer factor protects mice against lethal challenge with herpes simplex virus.

D Viza, J M Vich, J Phillips

    Cellular Immunology
    |July 1, 1986
    PubMed
    Summary

    Bovine transfer factor (TFd) specific to herpes simplex virus (HSV) demonstrated protective effects in mice against homologous HSV challenge. This study suggests animal models can effectively assay TFd potency for herpes virus applications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Transfer Factor as an Option for Managing the COVID-19 Pandemic.

    Folia biologica·2020
    Same author

    Transfer factor: an overlooked potential for the prevention and treatment of infectious diseases.

    Folia biologica·2013
    Same author

    Integration of e-learning resources into a medical school curriculum.

    Medical teacher·2011
    Same author

    Diffraction grating ruling in australia.

    Applied optics·2010
    Same author

    Three-wavelength device for all-optical signal processing.

    Optics letters·2009
    Same author

    The effect of mixed or sequential grazing of cattle and sheep on the faecal egg counts and growth rates of weaned lambs when treated with anthelmintics.

    Veterinary parasitology·2006

    Area of Science:

    • Immunology
    • Virology
    • Biotechnology

    Background:

    • Herpes simplex virus (HSV) infections pose significant health challenges.
    • Transfer factor (TFd) is a cell-free extract with potential immunomodulatory properties.
    • Specific TFd preparations may offer targeted antiviral protection.

    Purpose of the Study:

    • To investigate the efficacy of bovine-derived transfer factor (TFd) specific to HSV1 and HSV2 in protecting mice against lethal HSV challenge.
    • To determine if TFd specificity is crucial for protection against homologous viral strains.
    • To explore the dose-response relationship of TFd preparations in an animal model.

    Main Methods:

    • Calves were immunized with HSV1 or HSV2 to produce specific TFd.
    • Prepared TFd was administered to Swiss mice.

    Related Experiment Videos

  • Mice were subsequently challenged with lethal doses of HSV1 or HSV2.
  • Control groups received non-specific TFd (anti-CMV) or varying TFd concentrations.

    • Main Results:

    • TFd specific to HSV1 or HSV2 conferred protection against homologous viral challenge in mice.
    • Non-specific TFd (anti-CMV) failed to protect against HSV1 challenge, highlighting specificity.
    • A dose-dependent effect was observed, with reduced concentrations of TFd showing diminished efficacy.
    • Potent TFd preparations became ineffective at one-fifth of the original concentration.

    Conclusions:

    • Bovine transfer factor (TFd) specific to HSV demonstrates significant protective potential in an animal model.
    • The specificity of TFd is critical for effective protection against homologous herpes simplex virus infections.
    • Animal models, such as the mouse model used, are suitable for assessing the potency and efficacy of HSV-specific TFd preparations.